The Capital Gains Tax (CGT) is moving higher in the UK, and firms and individuals are adjusting their behaviour. One way to mitigate CGT is to invest in companies that qualify under the EIS/SEIS/VCT programs, as there are potentially no capital gains taxes paid at all.
Reacting to the tax increases installed by the Labour government, Calculus has announced the Knowledge Intensive EIS Fund.
Calculus is a company that aims to give investors access to a portfolio of high-growth, UK-based private companies.
Calculus stated that this is their third approved Knowledge Intensive (KI) Enterprise Investment Scheme (EIS) Funds and the first EIS Fund following the Autumn budget.
Under EIS, investors receive an immediate 30% income tax relief and 100% exemption from capital gains if held for several years.
The Fund’s goal is to return £2 tax free for every £1 invested by investing in a portfolio of private tech and healthcare companies.
John Glencross, Chief Executive and co-founder of Calculus Capital, says the qualified fund will enable easier tax planning while providing meaningful support to a new generation of UK companies driving the digital revolution.
Calculus highlights its current portfolio of companies includeing Oxford BioTherapeutics, a clinical stage oncology company; WorkL, a job marketplace; and Laverock, a Gene Editing induced Gene Silencing (GEiGS) platform.
Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!
